DEVICE FOR USE IN THE TREATMENT OF HEMORRHOIDS

(19)

(11)

EP 3 694 391 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	19.02.2025 Bulletin 2025/08

(45)	Mention of the grant of the patent:
	25.12.2024 Bulletin 2024/52

(21)	Application number: 18866512.9

(22)	Date of filing: 12.10.2018

(51)

International Patent Classification (IPC):

A61B 1/31^(2006.01)
A61B 1/015^(2006.01)
A61B 1/32^(2006.01)
A61B 17/064^(2006.01)
A61B 17/00^(2006.01)

A61B 17/04^(2006.01)
A61B 1/018^(2006.01)
A61B 17/06^(2006.01)
A61B 17/34^(2006.01)
A61B 17/30^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61B 1/015; A61B 1/018; A61B 1/31; A61B 1/32; A61B 17/0482; A61B 17/06004; A61B 17/064; A61B 2017/00818; A61B 2017/06042; A61B 2017/3405; A61B 2017/3452; A61B 17/3403; A61B 17/3462; A61B 2017/306; A61B 17/3421; A61B 2017/3445

(86)	International application number:
	PCT/SE2018/051044

(87)	International publication number:
	WO 2019/074439 (18.04.2019 Gazette 2019/16)

(54)	DEVICE FOR USE IN THE TREATMENT OF HEMORRHOIDS VORRICHTUNG ZUR VERWENDUNG BEI DER BEHANDLUNG VON HÄMORRHOIDEN DISPOSITIF DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DES HÉMORROÏDES

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

13.10.2017 SE 1751278

(43)	Date of publication of application:
	19.08.2020 Bulletin 2020/34

(73)	Proprietor: Developeration AB
	582 43 Linköping (SE)

(72)	Inventor:
	UNGERSTEDT, Johan 122 64 Enskede (SE)

(74)	Representative: AWA Sweden AB
	Box 45086 104 30 Stockholm 104 30 Stockholm (SE)

(56)

References cited: :

EP-A2- 2 163 211
US-A1- 2003 208 209
US-B2- 6 695 764

WO-A1-2006/033122
US-A1- 2010 130 857
US-B2- 7 695 432

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).